BIOXCEL THERAPEUTICS INC's ticker is BTAI and the CUSIP is 09075P105. A total of 37 filers reported holding BIOXCEL THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $184,000 | -59.9% | 4,000 | -62.3% | 0.00% | -50.0% |
| Q3 2020 | $459,000 | -18.2% | 10,600 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $561,000 | +99.6% | 10,600 | -15.9% | 0.00% | +100.0% |
| Q1 2020 | $281,000 | +126.6% | 12,600 | +48.2% | 0.00% | 0.0% |
| Q4 2019 | $124,000 | +5.1% | 8,500 | -50.0% | 0.00% | – |
| Q3 2019 | $118,000 | +594.1% | 17,000 | +962.5% | 0.00% | – |
| Q2 2019 | $17,000 | – | 1,600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| LUMINUS MANAGEMENT LLC | 157,099 | $4,565,000 | 0.66% |
| ACT CAPITAL MANAGEMENT, LLC | 42,000 | $1,221,000 | 0.63% |
| Knoll Capital Management, LLC | 20,000 | $581,000 | 0.30% |
| Artemis Investment Management LLP | 1,193,290 | $34,664,000 | 0.30% |
| Ghisallo Capital Management LLC | 225,000 | $6,539,000 | 0.25% |
| Monashee Investment Management LLC | 60,000 | $1,744,000 | 0.21% |
| AlphaCentric Advisors LLC | 25,000 | $727,000 | 0.20% |
| CAAS CAPITAL MANAGEMENT LP | 232,285 | $6,750,000 | 0.11% |
| AllSquare Wealth Management LLC | 5,402 | $157,000 | 0.09% |
| CNA FINANCIAL CORP | 9,479 | $275,000 | 0.08% |